Last Posted: Jun 19, 2024
- Using Wearable Sensors and Machine Learning to Assess Upper Limb Function in Huntington's Disease.
Ashkan Vaziri et al. Res Sq 2024 - Transfer of embryos with positive PGT-M results: Genetic Counselors' perspectives and ethical considerations.
Silvia Gunderson et al. J Genet Couns 2024 - An exploration of the genetics of the mutant Huntingtin (mHtt) gene in a cohort of patients with chorea from different ethnic groups in sub-Saharan Africa.
Mendi J Muthinja et al. Ann Hum Genet 2024 - What Is Huntington Disease?
R Marcus, JAMA, August 21, 2023 - A pilot evaluation of an 8-week mindfulness-based stress reduction program for people with pre-symptomatic Huntington's disease.
Sarah Velissaris et al. J Community Genet 2023 7 - Genetic screening for Huntington disease phenocopies in Sweden: A tertiary center case series focused on short tandem repeat (STR) disorders.
Martin Paucar et al. J Neurol Sci 2023 451120707 - Ethical Considerations in Clinical Trials for Rare Genetic Diseases: The Case of Huntington's Disease.
Adys Mendizabal et al. Am J Bioeth 2023 23(7) 94-96 - Intrapersonal and Interpersonal Disengagement Coping: Associations with Emotions of Youth At-Risk for Huntington's Disease.
Kelly H Watson et al. J Huntingtons Dis 2023 - Pharmacogenetics in the Treatment of Huntington’s Disease: Review and Future Perspectives
XG Gonzalez et al, J Pers Med, February 22, 2023 - The Nuclear Envelope in Ageing and Progeria.
Fragoso-Luna Adrián et al. Sub-cellular biochemistry 2023 10253-75 - Health related quality of life, service utilization and costs for patients with Huntington's disease in Norway.
van Walsem Marleen R et al. BMC health services research 2022 22(1) 1527 - Identification of psychoeducation needs and an intervention response for pre-symptomatic Huntington's disease.
Gluyas Cathy et al. Journal of community genetics 2022 1-9 - The Vasopressin 1a Receptor Antagonist SRX246 Reduces Aggressive Behavior in Huntington’s Disease
HT Mailbach et al, J Pers Medicine, September 22, 2022 - PAM-altering SNP-based allele-specific CRISPR-Cas9 therapeutic strategies for Huntington's disease.
Shin Jun Wan et al. Molecular therapy. Methods & clinical development 2022 26547-561 - Pepinemab antibody blockade of SEMA4D in early Huntington's disease: a randomized, placebo-controlled, phase 2 trial.
Feigin Andrew et al. Nature medicine 2022 8 - Clinical and molecular findings of intermediate allele carriers in the HTT gene from the Mexican Mestizo population.
Ramírez-García Miguel Ángel et al. Neuro-degenerative diseases 2022 - Canadian healthcare capacity gaps for disease-modifying treatment in Huntington's disease: a survey of current practice and modelling of future needs.
Bénard Angèle et al. BMJ open 2022 12(6) e062740 - Searching for Answers: Information-Seeking by Young People At-Risk for Huntington's Disease.
Chase Colby L et al. Journal of Huntington's disease 2022 - Predicting clinical scores in Huntington's disease: a lightweight speech test.
Riad Rachid et al. Journal of neurology 2022 - Predicting Severity of Huntington's Disease With Wearable Sensors.
Scheid Brittany H et al. Frontiers in digital health 2022 4874208
More
Search Result Summary
- CDC Information (0)
- NIH Information (0)
- CDC Publications (0)
- Hot Topics Archive (49)
- COVID-19 (6)
- Human Genome Epidemiologic Studies (190)
- GWAS Studies (4)
- Genomics Precision Health (146)
- Non-Genomics Precision Health (1)
- Pathogen Advanced Molecular Detection (0)
Disclaimer: Articles listed in the Public Health Genomics and Precision Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.